Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus

Tuberculosis (TB) is caused by the bacterial pathogen Mycobacterium tuberculosis (MTB) and is one of the principal reasons for mortality and morbidity worldwide. Currently, recommended anti-tuberculosis drugs include isoniazid, rifampicin, ethambutol, and pyrazinamide. TB treatment is lengthy and in...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Li Zhao, Ke Fan, Xuezhi Sun, Wei Li, Fenfen Qin, Liwen Shi, Feng Gao, Chunlan Zheng
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2024-01-01
Saila:	Frontiers in Immunology
Gaiak:	mycobacterium tuberculosis diabetes mellitus host-directed therapy drug-resistance immune
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1305325/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!